Tuesday Sep 9
Okay. We will go ahead and get started. Good afternoon everyone, and welcome to the Morgan Stanley Global Healthcare Conference.
Wed Sep 03, 2014
Celldex Announces Upcoming Presentation at the Morgan Stanley Healthcare Conference
Celldex Therapeutics, Inc. announced today that Anthony Marucci, President and Chief Executive Officer, will present a corporate overview at the Morgan Stanley Healthcare Conference on September 8, 2014 at 1:25 p.m. ET at the Grand Hyatt in New York City.
Mon Sep 01, 2014
Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014
Summary GlobalData's clinical trial report, "Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014" provides data on the Coronary Arteriosclerosis clinical trial scenario.
Wed Aug 27, 2014
Critical Alerts For General Electric, DSW, Celldex Therapeutics,...
To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.
Mon Aug 25, 2014
Celldex Offers A Broad Portfolio Of Oncology Solutions
Celldex' ACT-IV pivotal Phase III trial is fast approaching complete enrollment and will now read out in advance of Northwest Biotherapeutics DCVax-L registration study.